therapeutic efficacy evaluation of MM-PtNCs

After AKI modeling, the therapeutic efficacy was primarily evaluated through blood biochemical indicators, creatinine (CREA) and urea (UREA). Here is the raw data for following analysis.

在构建急性肾损伤（Acute Kidney Injury, AKI）模型后，治疗疗效主要通过血液生化指标肌酐（CREA）与尿素（UREA）进行评估。以下为用于后续分析的原始数据。